List of Tables
Table 1. Heparin (Low Molecular Weight) Market Trends
Table 2. Heparin (Low Molecular Weight) Market Drivers & Opportunity
Table 3. Heparin (Low Molecular Weight) Market Challenges
Table 4. Heparin (Low Molecular Weight) Market Restraints
Table 5. Global Heparin (Low Molecular Weight) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Heparin (Low Molecular Weight) Revenue Market Share by Company (2019-2024)
Table 7. Global Heparin (Low Molecular Weight) Sales Volume by Company (2019-2024) & (Kiloton)
Table 8. Global Heparin (Low Molecular Weight) Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Heparin (Low Molecular Weight) Price by Company (2019-2024) & (US$/Ton)
Table 10. Key Manufacturers Heparin (Low Molecular Weight) Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Heparin (Low Molecular Weight) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Heparin (Low Molecular Weight)
Table 13. Global Heparin (Low Molecular Weight) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin (Low Molecular Weight) as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Heparin (Low Molecular Weight) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Heparin (Low Molecular Weight) Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Heparin (Low Molecular Weight) Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Heparin (Low Molecular Weight) Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Heparin (Low Molecular Weight) Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Heparin (Low Molecular Weight) Sales Volume by Type: 2019 VS 2023 VS 2030 (Kiloton)
Table 22. Global Heparin (Low Molecular Weight) Sales Volume by Type (2019-2024) & (Kiloton)
Table 23. Global Heparin (Low Molecular Weight) Sales Volume by Type (2025-2030) & (Kiloton)
Table 24. Global Heparin (Low Molecular Weight) Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Heparin (Low Molecular Weight) Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Heparin (Low Molecular Weight) Price by Type (2019-2024) & (US$/Ton)
Table 27. Global Heparin (Low Molecular Weight) Price by Type (2025-2030) & (US$/Ton)
Table 28. Global Heparin (Low Molecular Weight) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Heparin (Low Molecular Weight) Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Heparin (Low Molecular Weight) Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Heparin (Low Molecular Weight) Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Heparin (Low Molecular Weight) Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Heparin (Low Molecular Weight) Sales Volume by Application: 2019 VS 2023 VS 2030 (Kiloton)
Table 34. Global Heparin (Low Molecular Weight) Sales Volume by Application (2019-2024) & (Kiloton)
Table 35. Global Heparin (Low Molecular Weight) Sales Volume by Application (2025-2030) & (Kiloton)
Table 36. Global Heparin (Low Molecular Weight) Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Heparin (Low Molecular Weight) Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Heparin (Low Molecular Weight) Price by Application (2019-2024) & (US$/Ton)
Table 39. Global Heparin (Low Molecular Weight) Price by Application (2025-2030) & (US$/Ton)
Table 40. Global Heparin (Low Molecular Weight) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Heparin (Low Molecular Weight) Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Heparin (Low Molecular Weight) Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Heparin (Low Molecular Weight) Sales Value by Region (2019-2024) & (%)
Table 44. Global Heparin (Low Molecular Weight) Sales Value by Region (2025-2030) & (%)
Table 45. Global Heparin (Low Molecular Weight) Sales Volume by Region (Kiloton): 2019 VS 2023 VS 2030
Table 46. Global Heparin (Low Molecular Weight) Sales Volume by Region (2019-2024) & (Kiloton)
Table 47. Global Heparin (Low Molecular Weight) Sales Volume by Region (2025-2030) & (Kiloton)
Table 48. Global Heparin (Low Molecular Weight) Sales Volume by Region (2019-2024) & (%)
Table 49. Global Heparin (Low Molecular Weight) Sales Volume by Region (2025-2030) & (%)
Table 50. Global Heparin (Low Molecular Weight) Average Price by Region (2019-2024) & (US$/Ton)
Table 51. Global Heparin (Low Molecular Weight) Average Price by Region (2025-2030) & (US$/Ton)
Table 52. Key Countries/Regions Heparin (Low Molecular Weight) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Heparin (Low Molecular Weight) Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Heparin (Low Molecular Weight) Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Heparin (Low Molecular Weight) Sales Volume, (2019-2024) & (Kiloton)
Table 56. Key Countries/Regions Heparin (Low Molecular Weight) Sales Volume, (2025-2030) & (Kiloton)
Table 57. Aspen Company Information
Table 58. Aspen Introduction and Business Overview
Table 59. Aspen Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 60. Aspen Heparin (Low Molecular Weight) Product Offerings
Table 61. Aspen Recent Development
Table 62. Sanofi-aventis Company Information
Table 63. Sanofi-aventis Introduction and Business Overview
Table 64. Sanofi-aventis Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 65. Sanofi-aventis Heparin (Low Molecular Weight) Product Offerings
Table 66. Sanofi-aventis Recent Development
Table 67. Pfizer Company Information
Table 68. Pfizer Introduction and Business Overview
Table 69. Pfizer Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 70. Pfizer Heparin (Low Molecular Weight) Product Offerings
Table 71. Pfizer Recent Development
Table 72. Opocrin Company Information
Table 73. Opocrin Introduction and Business Overview
Table 74. Opocrin Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. Opocrin Heparin (Low Molecular Weight) Product Offerings
Table 76. Opocrin Recent Development
Table 77. CSBIO Company Information
Table 78. CSBIO Introduction and Business Overview
Table 79. CSBIO Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. CSBIO Heparin (Low Molecular Weight) Product Offerings
Table 81. CSBIO Recent Development
Table 82. Dongying Tiandong Pharmaceutical Company Information
Table 83. Dongying Tiandong Pharmaceutical Introduction and Business Overview
Table 84. Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Product Offerings
Table 86. Dongying Tiandong Pharmaceutical Recent Development
Table 87. Changzhou Qianhong Bio-pharma Company Information
Table 88. Changzhou Qianhong Bio-pharma Introduction and Business Overview
Table 89. Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Product Offerings
Table 91. Changzhou Qianhong Bio-pharma Recent Development
Table 92. Techdow Company Information
Table 93. Techdow Introduction and Business Overview
Table 94. Techdow Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. Techdow Heparin (Low Molecular Weight) Product Offerings
Table 96. Techdow Recent Development
Table 97. Yantai Dongcheng Pharmaceutical Group Company Information
Table 98. Yantai Dongcheng Pharmaceutical Group Introduction and Business Overview
Table 99. Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 100. Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Product Offerings
Table 101. Yantai Dongcheng Pharmaceutical Group Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Heparin (Low Molecular Weight) Downstream Customers
Table 105. Heparin (Low Molecular Weight) Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin (Low Molecular Weight) Product Picture
Figure 2. Global Heparin (Low Molecular Weight) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Heparin (Low Molecular Weight) Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Heparin (Low Molecular Weight) Sales Volume (2019-2030) & (Kiloton)
Figure 5. Global Heparin (Low Molecular Weight) Sales Price (2019-2030) & (US$/Ton)
Figure 6. Heparin (Low Molecular Weight) Report Years Considered
Figure 7. Global Heparin (Low Molecular Weight) Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Heparin (Low Molecular Weight) Players Sales Volume Ranking (2023) & (Kiloton)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Heparin (Low Molecular Weight) Revenue in 2023
Figure 10. Heparin (Low Molecular Weight) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Enoxaparin Picture
Figure 12. Dalteparin Picture
Figure 13. Tinzaparin Picture
Figure 14. Fraxiparine Picture
Figure 15. Global Heparin (Low Molecular Weight) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Heparin (Low Molecular Weight) Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Heparin (Low Molecular Weight) Sales Volume by Type (2019 VS 2023 VS 2030) & (Kiloton)
Figure 18. Global Heparin (Low Molecular Weight) Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Heparin (Low Molecular Weight) Price by Type (2019-2030) & (US$/Ton)
Figure 20. Product Picture of Treatment of Venous Thromboembolism
Figure 21. Product Picture of Complications of Pregnancy
Figure 22. Product Picture of Cardioversion of Atrial Fibrillation/Flutter
Figure 23. Product Picture of Others
Figure 24. Global Heparin (Low Molecular Weight) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Heparin (Low Molecular Weight) Sales Value Market Share by Application, 2023 & 2030
Figure 26. Global Heparin (Low Molecular Weight) Sales Volume by Application (2019 VS 2023 VS 2030) & (Kiloton)
Figure 27. Global Heparin (Low Molecular Weight) Sales Volume Market Share by Application, 2023 & 2030
Figure 28. Global Heparin (Low Molecular Weight) Price by Application (2019-2030) & (US$/Ton)
Figure 29. North America Heparin (Low Molecular Weight) Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Heparin (Low Molecular Weight) Sales Value by Country (%), 2023 VS 2030
Figure 31. Europe Heparin (Low Molecular Weight) Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Heparin (Low Molecular Weight) Sales Value by Country (%), 2023 VS 2030
Figure 33. Asia Pacific Heparin (Low Molecular Weight) Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Heparin (Low Molecular Weight) Sales Value by Country (%), 2023 VS 2030
Figure 35. South America Heparin (Low Molecular Weight) Sales Value (2019-2030) & (US$ Million)
Figure 36. South America Heparin (Low Molecular Weight) Sales Value by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Heparin (Low Molecular Weight) Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Heparin (Low Molecular Weight) Sales Value by Country (%), 2023 VS 2030
Figure 39. Key Countries/Regions Heparin (Low Molecular Weight) Sales Value (%), (2019-2030)
Figure 40. Key Countries/Regions Heparin (Low Molecular Weight) Sales Volume (%), (2019-2030)
Figure 41. United States Heparin (Low Molecular Weight) Sales Value, (2019-2030) & (US$ Million)
Figure 42. United States Heparin (Low Molecular Weight) Sales Value by Type (%), 2023 VS 2030
Figure 43. United States Heparin (Low Molecular Weight) Sales Value by Application (%), 2023 VS 2030
Figure 44. Europe Heparin (Low Molecular Weight) Sales Value, (2019-2030) & (US$ Million)
Figure 45. Europe Heparin (Low Molecular Weight) Sales Value by Type (%), 2023 VS 2030
Figure 46. Europe Heparin (Low Molecular Weight) Sales Value by Application (%), 2023 VS 2030
Figure 47. China Heparin (Low Molecular Weight) Sales Value, (2019-2030) & (US$ Million)
Figure 48. China Heparin (Low Molecular Weight) Sales Value by Type (%), 2023 VS 2030
Figure 49. China Heparin (Low Molecular Weight) Sales Value by Application (%), 2023 VS 2030
Figure 50. Japan Heparin (Low Molecular Weight) Sales Value, (2019-2030) & (US$ Million)
Figure 51. Japan Heparin (Low Molecular Weight) Sales Value by Type (%), 2023 VS 2030
Figure 52. Japan Heparin (Low Molecular Weight) Sales Value by Application (%), 2023 VS 2030
Figure 53. South Korea Heparin (Low Molecular Weight) Sales Value, (2019-2030) & (US$ Million)
Figure 54. South Korea Heparin (Low Molecular Weight) Sales Value by Type (%), 2023 VS 2030
Figure 55. South Korea Heparin (Low Molecular Weight) Sales Value by Application (%), 2023 VS 2030
Figure 56. Southeast Asia Heparin (Low Molecular Weight) Sales Value, (2019-2030) & (US$ Million)
Figure 57. Southeast Asia Heparin (Low Molecular Weight) Sales Value by Type (%), 2023 VS 2030
Figure 58. Southeast Asia Heparin (Low Molecular Weight) Sales Value by Application (%), 2023 VS 2030
Figure 59. India Heparin (Low Molecular Weight) Sales Value, (2019-2030) & (US$ Million)
Figure 60. India Heparin (Low Molecular Weight) Sales Value by Type (%), 2023 VS 2030
Figure 61. India Heparin (Low Molecular Weight) Sales Value by Application (%), 2023 VS 2030
Figure 62. Heparin (Low Molecular Weight) Industrial Chain
Figure 63. Heparin (Low Molecular Weight) Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
